Life Saving Drugs Program – Perinatal- or infantile-onset hypophosphatasia (HPP) – Reapplication
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
This form includes:
- patient eligibility checklist
- privacy notice and patient consent
- dosing details
- treating physician’s declaration
- reapplication checklist.